Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization-Reference-Cited by-同舟云学术

Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization

Published:2015-04-10 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Francica Joseph R., ,Sheng Zizhang,Zhang Zhenhai,Nishimura Yoshiaki,Shingai Masashi,Ramesh Akshaya,Keele Brandon F.,Schmidt Stephen D.,Flynn Barbara J.,Darko Sam,Lynch Rebecca M.,Yamamoto Takuya,Matus-Nicodemos Rodrigo,Wolinsky David,Nason Martha,Valiante Nicholas M.,Malyala Padma,De Gregorio Ennio,Barnett Susan W.,Singh Manmohan,O’Hagan Derek T.,Koup Richard A.,Mascola John R.,Martin Malcolm A.,Kepler Thomas B.,Douek Daniel C.,Shapiro Lawrence,Seder Robert A.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7565.pdf

Reference70 articles.

1. Excler, J. L., Robb, M. L. & Kim, J. H. HIV-1 vaccines: challenges and new perspectives. Hum. Vaccin. Immunother. 10, 1734–1746 (2014) .

2. Klein, F. et al. Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199–1204 (2013) .

3. Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466–470 (2011) .

4. Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856–861 (2010) .

5. Mascola, J. R. & Haynes, B. F. HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol. Rev. 254, 225–244 (2013) .

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen;ACS Nano;2024-06-17

2. HIV-1 neutralizing antibodies in SHIV-infected macaques recapitulate structurally divergent modes of human V2 apex recognition with a single D gene;2024-06-12

3. Sustained vaccine exposure elicits more rapid, consistent, and broad humoral immune responses to multivalent influenza vaccines;2024-04-30

4. Alternative substitutions of N332 in HIV-1 _AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan;mBio;2024-04-10

5. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial;PLOS Medicine;2024-03-19